Matthew Lining, DPM
Foot & Ankle Surgery · Carmel, INNPI 1124525092
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $19,250 of the $27,076 with a category attached, or 71.1%. Nvision Biomedical Technologies, Inc. accounts for 87.6% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2022 at $15,002 and has fallen 92.6% since, to $1,110 in 2025.
Across 58 payments — averaging $466.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nvision Biomedical Technologies, Inc.$24K
- Crossroads Orthopedics, LLC$1K
- Medline Industries LP$714
- Organogenesis Inc.$168
- Flower Orthopedics Coporation$138
- Checkpoint Surgical, Inc$125
- plus $991 from 19 others
What the payments were for
- Consulting fees$19,25071%
- Travel & lodging$4,00115%
- Food & beverage$2,62510%
- Education$1,2004%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nvision Biomedical Technologies, Inc. | 13 | $23,719 |
| Crossroads Orthopedics, LLC | 2 | $1,220 |
| Medline Industries LP | 6 | $714 |
| Organogenesis Inc. | 2 | $168 |
| Flower Orthopedics Coporation | 1 | $138 |
| Checkpoint Surgical, Inc | 1 | $125 |
| Paratek Pharmaceuticals, Inc. | 7 | $121 |
| Linvatec Corporation | 1 | $120 |
| Stryker | 3 | $111 |
| Abbott | 1 | $101 |
| Mimedx Group, Inc. | 2 | $97 |
| Epsfl, LLC | 2 | $56 |
| Johnson & Johnson | 2 | $56 |
| Averitas Pharma Inc. | 2 | $51 |
| Triad Life Sciences Inc. | 1 | $48 |
| Smith+Nephew | 2 | $40 |
| DJO, LLC | 2 | $39 |
| Sanara Medtech Inc. | 1 | $34 |
| Vertex | 1 | $25 |
| Bioventus LLC | 1 | $20 |
| Amgen | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $15 |
| GRT US Holding, Inc. | 1 | $15 |
| Nevro Corp. | 1 | $14 |
| Paragon 28, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Foot/ankle products$14,835
- Foot and Ankle$7,886
- Lapidus Wedge$998
- Apligraf$151
- Checkpoint Stimulators$125
- LINVATEC EXTREMITIES$120
- Supera peripheral stent system$101
How this compares
$27,076 in reported general payments places this provider in the 85th percentile of 212 foot & ankle surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 132 | $841 |
| Doxycycline Monohydrate | 28 | $611 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 58 | $458 |
| Terbinafine Hcl | 30 | $271 |
| Cephalexin | 11 | $211 |
| Meloxicam | 73 | $109 |
| Methylprednisolone | 18 | $106 |
| Allopurinol | 14 | $51 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Carmel
- Christopher WintersCarmel$152K
- John MillerCarmel$30K
- Andrew WohlerCarmel$29K
- Steven HerbstMuncie$1.6M
- Douglas BlacklidgeKokomo$689K
- Patrick DeheerIndianapolis$493K
- Scott NevilleMooresville$353K
- Travis MontgomeryWestfield$345K
- Robert Clemency IiiSchererville$215K
- William AdamsGreenfield$178K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.